These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3161086)

  • 21. [Structure-activity relationships in the quinolone group: antibacterial activity of two new compounds (author's transl)].
    Thibault M; Koumaré B; Soussy CJ; Duval J
    Ann Microbiol (Paris); 1981; 132(3):267-81. PubMed ID: 6457546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A study of the in vitro sensitivity of Enterobacteriaceae and Pseudomonas aeruginosa to 7 antimicrobial agents].
    Lynch MB; Mimica I; Valenzuela MC; Vilches A; Abarca S
    Rev Med Chil; 1972 Jan; 100(1):14-5. PubMed ID: 4622217
    [No Abstract]   [Full Text] [Related]  

  • 23. A norfloxacin dose finding study for selective decontamination of the digestive tract in pigs.
    Van der Waaij LA; Messerschmidt O; Van der Waaij D
    Epidemiol Infect; 1989 Feb; 102(1):93-103. PubMed ID: 2917619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Norfloxacin in acute urinary tract infections.
    Deaney NB; Vogel R; Vandenburg MJ; Currie WJ
    Practitioner; 1984 Jan; 228(1387):111-7. PubMed ID: 6229726
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of the in vitro activity of ciprofloxacin (Bay o 9867) and norfloxacin against gastrointestinal tract pathogens.
    Diez-Enciso M; Mas-Jimenez G; Velasco-Cerrudo A; Gutierrez-Altes A
    Eur J Clin Microbiol; 1984 Aug; 3(4):367. PubMed ID: 6237905
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative in vitro activity of norfloxacin and four other chemotherapeutics against urinary gram-negative isolates.
    Esposito S; Galante D; Pennucci C; Barba D; Limauro D; Scioli C
    Chemioterapia; 1984 Jun; 3(3):196-9. PubMed ID: 6241506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved high-performance liquid chromatographic determination of pefloxacin and its metabolite norfloxacin in human plasma and tissue.
    Montay G; Tassel JP
    J Chromatogr; 1985 Apr; 339(1):214-8. PubMed ID: 3160717
    [No Abstract]   [Full Text] [Related]  

  • 28. Belgian multicenter in vitro study of norfloxacin.
    Verbist L
    Acta Clin Belg; 1985; 40(3):167-73. PubMed ID: 3161262
    [No Abstract]   [Full Text] [Related]  

  • 29. [Selective decontamination of digestive tract. A way to control intensive care infections].
    Blomqvist H; Burman L; Ekwall E
    Lakartidningen; 2004 Mar; 101(11):966-7. PubMed ID: 15055116
    [No Abstract]   [Full Text] [Related]  

  • 30. Selective elimination of Enterobacteriaceae from the digestive tract in rats with trimethoprim.
    Koopman JP; Kennis HM; Stadhouders AM; de Boer H; Hectors MP
    Z Versuchstierkd; 1985; 27(3-4):143-8. PubMed ID: 4050161
    [No Abstract]   [Full Text] [Related]  

  • 31. Bacteriological aspects of selective decontamination of the digestive tract as a method of infection prevention in granulocytopenic patients.
    de Vries-Hospers HG; Sleijfer DT; Mulder NH; van der Waaij D; Neiweg HO; van Saene HK
    Antimicrob Agents Chemother; 1981 May; 19(5):813-20. PubMed ID: 7027923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prostatic concentrations of norfloxacin using HPLC].
    Bologna M; Cavicchio GC; Forchetti CM; Rucci A; Di Nicola G; Vaggi L
    G Ital Chemioter; 1984; 31(1-2):59-63. PubMed ID: 6236124
    [No Abstract]   [Full Text] [Related]  

  • 33. High-performance liquid chromatographic procedure for the quantitation of norfloxacin in urine, serum and tissues.
    Forchetti C; Flammini D; Carlucci G; Cavicchio G; Vaggi L; Bologna M
    J Chromatogr; 1984 Jul; 309(1):177-82. PubMed ID: 6237115
    [No Abstract]   [Full Text] [Related]  

  • 34. Antibacterial efficacy of norfloxacin, trimethoprim-sulfamethoxazole, and gentamicin in experimentally-infected normal and streptozotocin-induced diabetic mice.
    Fromtling RA; Abruzzo GK; Gadebusch HH
    Methods Find Exp Clin Pharmacol; 1984 Dec; 6(12):731-5. PubMed ID: 6241648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro sensitivity pattern of gram negative pathogens to nalidixic acid.
    Chitkara YK
    Indian J Pathol Bacteriol; 1969 Oct; 12(4):162-8. PubMed ID: 4990210
    [No Abstract]   [Full Text] [Related]  

  • 36. [Quinolones: antimicrobials for the 90s].
    Timerman A
    AMB Rev Assoc Med Bras; 1987; 33(5-6):81-2. PubMed ID: 3502367
    [No Abstract]   [Full Text] [Related]  

  • 37. Is selective decontamination of the digestive tract beneficial in liver transplant patients? Interim results of a prospective, randomized trial.
    Badger IL; Crosby HA; Kong KL; Baker JP; Hutchings P; Elliott TS; McMaster P; Bion JF; Buckels JA
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1460-1. PubMed ID: 1989265
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of norfloxacin on Staphylococcus aureus and Pseudomonas aeruginosa in broth, serum and in combination with human polymorphonuclear leukocytes.
    Daschner F; Bassler M; Bosbach U
    Eur J Clin Microbiol; 1983 Jun; 2(3):274-6. PubMed ID: 6224689
    [No Abstract]   [Full Text] [Related]  

  • 39. Norfloxacin and the antibacterial gamma pyridone beta carboxylic acids.
    Newsom SW; Matthews J; Amphlett M; Warren RE
    J Antimicrob Chemother; 1982 Jul; 10(1):25-30. PubMed ID: 6213593
    [No Abstract]   [Full Text] [Related]  

  • 40. Determination of norfloxacin, a new nalidixic acid analog, in human serum and urine by high-performance liquid chromatography.
    Boppana VK; Swanson BN
    Antimicrob Agents Chemother; 1982 May; 21(5):808-10. PubMed ID: 6213199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.